Thermo Fisher Bioproduction Insights

  1. Delivering Global Media Manufacturing Consistency Through Site-To-Site Equivalency 7/8/2024

    Explore a program focused on achieving process consistency through risk mitigation in four key areas: raw materials sourcing, equipment, manufacturing processes, and finished product testing.

  2. Rapid, Seamless Upstream Process Development And Scale-Up For CHO-K1 Cells 6/28/2024

    Accelerate your biotech company's scale-up process while delivering consistent and strong cell growth, productivity, and product quality.

  3. Comparing Real-Time And Digital PCR Technologies 6/20/2024

    Which PCR technologies are the most effective? Compare digital PCR (dPCR) and real-time or quantitative PCR (qPCR) to determine the best choice for your labs.

  4. Lentiviral Vector Characterization For Cell And Gene Therapy Manufacturing 6/20/2024

    This study focuses on characterizing recombinant LVVs used in gene-modified cell therapies, utilizing two real-time PCR assays adapted to the QuantStudio™ Absolute Q™ Digital PCR System.

  5. Residual DNA Testing: Homebrew vs Off-The-Shelf Solutions 6/19/2024

    Compare the steps to setting up your own residual DNA testing solution to the steps for setting up a commercial residual DNA testing solution.

  6. High-Performance Extraction And Quantitation Of Host-Cell Residual DNA 6/19/2024

    This study presents a high-efficiency method for extracting and quantifying residual DNA from host cells using a semi-automated, high-throughput workflow.

  7. Maximizing Scale-Up Efficiency Of A mAb Upstream Process 6/17/2024

    This study demonstrated the effectiveness of a medium and feed system when tested at three different scales for its ability to high-quality, fed-batch monoclonal antibodies.

  8. Mycoplasma Testing In Monoclonal Antibody Production 6/17/2024

    Prevent costly disruptions in your bioproduction process. Discover how a PCR-based method can quickly detect the presence of mycoplasmas in raw materials, cell banks, and in-process and lot-release samples.

  9. Simultaneous Extraction Of Mycoplasma, MMV, And Vesivirus Nucleic Acids From A Single Sample 6/7/2024

    Achieve early detection of cell culture contamination with a nucleic acid extraction system to provide an integrated system for rapid and sensitive detection of mycoplasma, MMV, and vesivirus.

  10. Meeting Regulatory Requirements With Confidence 6/7/2024

    An outbreak of mycoplasma can halt a biopharmaceutical facility's production for months. Explore the impact of mycoplasma contamination and the most accurate and sensitive way to detect it.